ArticleJournal of medical biochemistry2025

Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk.

Aleksandra Klisic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.